AnnualReports.com – the leading provider of online annual reports to individual and institutional investors.

Cyclacel Pharmaceuticals, Inc.

Home » NASDAQ » Healthcare » Cyclacel Pharmaceuticals, Inc.

Cyclacel is a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders.

  • Annual Reports
  • Investor Fact Sheets
View Online Reports: Order Free Hardcopy You can request a free hardcopy of this report mailed to you by clicking the button below.
Add Annual Report

View Online Reports:
No responsibility reports added yet

Browse Reports